OmniAb (OABI) Cash from Investing Activities (2021 - 2026)

OmniAb (OABI) reported Cash from Investing Activities of $8.4 million for Q1 2026, up 1060.82% year-over-year from $726727.6 in Q1 2025, and up 211.18% quarter-over-quarter from $2.7 million in Q4 2025.

OmniAb (OABI) Cash from Investing Activities (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Cash from Investing Activities data on file, last reported at $8.4 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $8.4 million, up 1060.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (down 7.55% YoY), and the FY2025 annual result was $6.5 million, down 82.93% from the prior year.
  • Cash from Investing Activities grew to $8.4 million in Q1 2026 per OABI's latest filing, from $2.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $19.9 million in Q1 2024 and troughed at -$60.2 million in Q4 2022.
  • A 5-year average of -$2.3 million and a median of $2.7 million in 2025 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities tumbled 841.78% in 2023, then soared 1060.82% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at -$60.2 million in 2022, then soared by 107.86% to $4.7 million in 2023, then tumbled by 91.86% to $385000.0 in 2024, then soared by 604.16% to $2.7 million in 2025, then soared by 211.18% to $8.4 million in 2026.
  • Business Quant data shows OABI's Cash from Investing Activities at $8.4 million in Q1 2026, $2.7 million in Q4 2025, and -$7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 8.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.44 Mn
Mar 31, 2026 8.44 Mn
Dec 31, 2025 2.71 Mn
Dec 31, 2025 2.71 Mn
Sep 30, 2025 -7.67 Mn
Sep 30, 2025 -7.67 Mn
Jun 30, 2025 12.30 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 -878,000.00
Mar 31, 2025 -878,000.00
Dec 31, 2024 385,000.00
Dec 31, 2024 385,000.00
Sep 30, 2024 4.45 Mn
Sep 30, 2024 4.45 Mn
Jun 30, 2024 13.11 Mn
Jun 30, 2024 13.11 Mn
Mar 31, 2024 19.94 Mn
Mar 31, 2024 19.94 Mn
Dec 31, 2023 4.73 Mn
Dec 31, 2023 4.73 Mn